Seeing Is Believing
Healthcare - Sector
G1 Therapeutics's activity chart (see below) currently has 75 price targets and 76 ratings on display.
Analysts average stock forecasts to be materialized ratio is 22.88% with an average time for these price targets to be met of 58.45 days.
Most recent stock forecast was given by from NEEDHAM on 07-Aug-2024. First documented stock forecast 12-Jun-2017.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-May-2022
$6
2 years 2 months 1 days ago
(07-Aug-2024)
1/12 (8.33%)
$3.8 (172.73%)
43
Sell Since 07-Aug-2024
$7.15
2 years 2 months 1 days ago
(07-Aug-2024)
5/7 (71.43%)
$0.09 (1.27%)
39
Buy Since 26-Jun-2020
2 years 2 months 1 days ago
(07-Aug-2024)
0/3 (0%)
$37.84 (234.16%)
Buy Since 17-Sep-2018
$3
$-4.15 (-58.04%)
$9
2 years 3 months 13 days ago
(25-Jun-2024)
1/13 (7.69%)
$0.8 (36.36%)
17
Buy Since 16-Sep-2022
$4
$-3.15 (-44.06%)
$5
2 years 7 months 25 days ago
(13-Feb-2024)
4/9 (44.44%)
$1.9 (90.48%)
189
What is GTHX (G1 Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on GTHX (G1 Therapeutics)?
Which analyst has the most public recommendations on GTHX (G1 Therapeutics)?
Which analyst is the currently most bullish on GTHX (G1 Therapeutics)?
Which analyst is the currently most reserved on GTHX (G1 Therapeutics)?